The clinical trial imaging services category is anticipated to grow at a CAGR of 8.05% from 2023 to 2030. North America holds the largest category share at about 41%.The rising number of Contract Research Organizations (CROs) along with biotechnology and pharmaceutical companies, the increasing presence of chronic health diseases among the population, the development of innovative imaging techniques, and rising R&D investment to develop new drugs and therapies are some of the key factors driving the growth. https://tinyurl.com/379h929b
Like
Comment
Share
